]>
IRCT20200126046263N1 IRCT 2020-02-18 Ahvaz University of Medical Sciences Investigation of efficacy of ginger consumption in migraine prophylaxis in patient with migraine Investigation of efficacy of ginger consumption in migraine prophylaxis in patient with migraine 2020-02-04 anticipated 108 Complete https://irct.ir/trial/45399 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: The total number of specimens randomly assigned by the process will be divided into two groups by random random blocks and each group will consist of 54 persons. The blocking method will be used for randomization. To do this, a random allocation sequence will be created through the reputable website https://www.sealedenvelope.com/simple-randomiser/v1/lists, Blinding description: This study is a double blind clinical trial (participant, researcher). Ginger and placebo supplements will be packaged in similar boxes, and the researcher and patients will not be informed of the contents of the packs until the end of the study. 3 migraine. Intervention 1: Intervention group: Two 500 mg ginger tablets daily for 3 month. Intervention 2: Control group: Two 500 mg placebo tablets daily (containing drug starch) for 3 months. Yes - There is a plan to make this available What will be shared: - When: - To whom: - Conditions: - Where to obtain: - How to obtain: - Comments:
public Forooh Anjiri Zadeh
Ahvaz Jundishapur University of Medical Sciences, Golestan Ave.
Ahvaz Iran (Islamic Republic of) 15794-61357 +98 61 3337 8721 foroogh_anjirizadeh@yahoo.com Ahvaz University of Medical Sciences scientific Bijan Helli
Department of Nutrition, Faculty of Paramedical Sciences, Ahvaz Jundishapur University of Medical Sciences, Golestan Ave.
Ahvaz Iran (Islamic Republic of) 15794-61357 +98 61 3337 8721 helli-b@ajums.ac.ir Ahvaz University of Medical Sciences Iran (Islamic Republic of) 18 to 50 years Migraine history with or without migraine is according to the International Headache Association (IHS) standard, which is at least one year after diagnosis. Diagnosis of mild to severe migraine (defined as the number of headache attacks 2 to 15 times a month, or less frequent and severe attacks that cause a person's disability and disruption in their daily routine). 18 years 50 years Both Non-migraine headaches Allergy to ginger Other neurological diseases (stroke, Alzheimer's, etc.) taking anticoagulants Pregnant and lactating women G43 Migraine Treatment - Other Placebo Intervention group: Two 500 mg ginger tablets daily for 3 month Control group: Two 500 mg placebo tablets daily (containing drug starch) for 3 months Headache. Timepoint: Measurement at baseline (Before the Intervention) and at the end of first and third months after supplementation. Method of measurement: MIDAS. Intensity and frequency. Timepoint: Measurement at baseline (Before the Intervention) and at the end of first and third months after supplementation. Method of measurement: questionnaire. Ahvaz University of Medical Sciences Approved 2019-12-28 Ethics committee of Ahvaz Jundishapur University of Medical Sciences Ahvaz Jundishapur University of Medical Sciences Ahvaz Khouzestan Iran (Islamic Republic of)